Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Nicolay

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 4, 2017
[Treatment of mycosis fungoides and Sézary syndrome]J P Nicolay, C Assaf
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 7, 2014
[Management of cutaneous lymphomas]J P Nicolay, C-D Klemke
Journal of Psychopharmacology (Oxford, England)|April 7, 2009
Lithium-induced suicidal erythrocyte deathJ P Nicolay, S Gatz, F Lang, et al.
Clinical and Experimental Dermatology|April 21, 2015
A new subtype of pachydermodactyly: unilateral pachydermodactyly transgrediensJ P Nicolay, J Faulhaber, H Kutzner, et al.
The British Journal of Dermatology|November 6, 2020
The importance of assessing blood tumour burden in cutaneous T-cell lymphomaM H Vermeer, J P Nicolay, J J Scarisbrick, et al.
The British Journal of Dermatology|April 20, 2012
Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cellsM Felcht, M Heck, C Weiss, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 17, 2021
Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trialR A Cowan, J J Scarisbrick, P L Zinzani, et al.
Experimental Dermatology|September 2, 2024
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patientsS Melchers, M Roemer, J D Albrecht, et al.
The British Journal of Dermatology|April 14, 2015
Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 casesC D Klemke, N Booken, C Weiss, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 20, 2020
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre studyM-C Brüggen, J Valencak, R Stranzenbach, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 4, 2017
[Treatment of mycosis fungoides and Sézary syndrome]J P Nicolay, C Assaf
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 7, 2014
[Management of cutaneous lymphomas]J P Nicolay, C-D Klemke
Journal of Psychopharmacology (Oxford, England)|April 7, 2009
Lithium-induced suicidal erythrocyte deathJ P Nicolay, S Gatz, F Lang, et al.
Clinical and Experimental Dermatology|April 21, 2015
A new subtype of pachydermodactyly: unilateral pachydermodactyly transgrediensJ P Nicolay, J Faulhaber, H Kutzner, et al.
The British Journal of Dermatology|November 6, 2020
The importance of assessing blood tumour burden in cutaneous T-cell lymphomaM H Vermeer, J P Nicolay, J J Scarisbrick, et al.
The British Journal of Dermatology|April 20, 2012
Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cellsM Felcht, M Heck, C Weiss, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 17, 2021
Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trialR A Cowan, J J Scarisbrick, P L Zinzani, et al.
Experimental Dermatology|September 2, 2024
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patientsS Melchers, M Roemer, J D Albrecht, et al.
The British Journal of Dermatology|April 14, 2015
Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 casesC D Klemke, N Booken, C Weiss, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 20, 2020
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre studyM-C Brüggen, J Valencak, R Stranzenbach, et al.
Pageof 2